Back to GOLDMAN SACHS GROUP INC GOLDMAN SACHS GROUP INC

FDMTFDMT
7 quarters

Position history for GOLDMAN SACHS GROUP INCGOLDMAN SACHS GROUP INC's holdings in 4D MOLECULAR THERAPEUTICS IN

GOLDMAN SACHS GROUP INC holds 4.3M shares of FDMT (4D MOLECULAR THERAPEUTICS IN), worth $56.6M as of 2026-Q2. The position was increased (+1.3% shares). FDMT represents 0.0% of GOLDMAN SACHS GROUP INC's portfolio.

Current Value

$56.6M

Current Shares

4.3M

Total Value Change

+$32.8M

Total Shares Change

-16,305

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
4.3M
+1.3%
$56.6M0.0%$13.30
30
2026-Q1
Decreased
4.2M
-2.3%
$39.2M0.0%$8.46
0
2025-Q4
Increased
4.3M
+4.2%
$32.3M0.0%$7.58
30
2025-Q3
Decreased
4.1M
-0.7%
$35.9M0.0%$8.35
0
2025-Q2
Decreased
4.2M
-0.2%
$15.4M0.0%$3.84
0
2025-Q1
Decreased
4.2M
-2.5%
$13.5M0.0%$3.63
0
2024-Q4
New
4.3M
-
$23.8M0.0%$5.30
40

Other major holders of FDMT: VIKING GLOBAL INVESTORS LP, RA CAPITAL MANAGEMENT, L.P., BlackRock Finance, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used